AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Vivani Medical, Inc. Common Stock (DE)
XNAS · usd
SIC 3845 · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
FIGI BBG002ZQP3J5
1.11▲ 0.02 (1.83%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
1.09
Day's Range
1.08 – 1.11
52-Week Range
0.92 – 1.81
Volume
85.8K
Avg Volume
174.3K
Share Statistics
Shares Outstanding
Employees
36
Exchange
XNAS
Listed
2022-08-31
Share count as of August 13, 2026

Vivani Medical, Inc. Common Stock (DE) (VANI) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Vivani Medical, Inc. Common Stock (DE) (VANI)
What is Vivani Medical, Inc. Common Stock (DE)'s Market Cap?
Vivani Medical, Inc. Common Stock (DE)'s Market Cap is $100.1M, based on as-reported figures from SEC (XBRL) filings.
What is Vivani Medical, Inc. Common Stock (DE)'s Revenue (TTM)?
Vivani Medical, Inc. Common Stock (DE)'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Vivani Medical, Inc. Common Stock (DE)'s Net Income (TTM)?
Vivani Medical, Inc. Common Stock (DE)'s Net Income (TTM) is -$26.3M, based on as-reported figures from SEC (XBRL) filings.
What is Vivani Medical, Inc. Common Stock (DE)'s EBITDA?
Vivani Medical, Inc. Common Stock (DE)'s EBITDA is -$26.9M, based on as-reported figures from SEC (XBRL) filings.
What is Vivani Medical, Inc. Common Stock (DE)'s Diluted EPS (TTM)?
Vivani Medical, Inc. Common Stock (DE)'s Diluted EPS (TTM) is -0.29, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · VANIAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating expenses:
Research and development, net of grants
General and administrative, net of grants
Total operating expenses
Loss from operations
Other income, net
Net loss
Net loss per common share - basic (in dollars per share)
Net loss per common share - diluted (in dollars per share)